Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.63 M USD
0.00 USD
1.12 M
About Ampio Pharmaceuticals, Inc.
Sector
CEO
Michael A. Martino
Headquarters
Englewood
Website
Founded
2008
FIGI
BBG000JKSJP5
Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AMPE is 0.0022 USD — it hasn't changed in the past 24 hours. Watch Ampio Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ampio Pharmaceuticals, Inc. stocks are traded under the ticker AMPE.
AMPE stock has fallen by −54.55% compared to the previous week, the month change is a −54.55% fall, over the last year Ampio Pharmaceuticals, Inc. has showed a −99.92% decrease.
AMPE reached its all-time high on Oct 24, 2013 with the price of 10.8600 USD, and its all-time low was 0.000001 USD and was reached on Jul 29, 2024. View more price dynamics on AMPE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AMPE stock is 54.55% volatile and has beta coefficient of −0.18. Track Ampio Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Ampio Pharmaceuticals, Inc. there?
Today Ampio Pharmaceuticals, Inc. has the market capitalization of 1.14 K, it has decreased by −54.56% over the last week.
Yes, you can track Ampio Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Ampio Pharmaceuticals, Inc. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
No, AMPE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 6.00 employees. See our rating of the largest employees — is Ampio Pharmaceuticals, Inc. on this list?
Like other stocks, AMPE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ampio Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ampio Pharmaceuticals, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ampio Pharmaceuticals, Inc. stock shows the sell signal. See more of Ampio Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.